← Back to research updates

ClinicalTrials.gov · Trial registry entry · 2026-11-13

A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

Reading list (0) →

Saved in this browser. Sign in to sync across devices.

WHAT THIS SOURCE TELLS US

ClinicalTrials.gov listing updated 2026-11-13. Status: COMPLETED; phase: PHASE3. Registration is not proof of benefit or safety.

What is the evidence status?

This is a registry record for a planned or ongoing study. Registration and recruitment do not show that the intervention is effective or safe.

Automatically indexed from an official source. This item has not received a NeuroCoach clinical review.

Read the original source

Open the original ClinicalTrials.gov record ↗

Questions worth asking

  • Which diagnosis and age group did this study actually examine?
  • Was there a control group and were clinically meaningful outcomes reported?
  • What was the safety follow-up, especially for people with several diagnoses?
  • Does a clinician familiar with the person’s history think it is relevant?

Research updates are educational, not individual medical advice. Do not start or stop any treatment based on a headline.